Clients News • MC Services corporate website
5522
page-template-default,page,page-id-5522,bridge-core-2.1.4,qode-listing-1.0.1,qode-social-login-1.0,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode-title-hidden,paspartu_enabled,qode_grid_1400,footer_responsive_adv,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-20.1,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,bridge-child,wpb-js-composer js-comp-ver-6.7.0,vc_responsive

CLIENT NEWS

 

 

  • EsoCap supports first European EoE Day of the European Society of Eosinophilic Oesophagitis on May 22, 2022
    20 May 2022
    www.esocapbiotech.ch
  • Spexis to present at H.C. Wainwright Global Investment Conference
    19 May 2022
    www.spexisbio.com
  • Abivax announces annual ordinary and extraordinary general meeting on June 9, 2022, and the availability of the preparatory documents
    18 May 2022
    www.abivax.com
  • InflaRx to Present at the H.C. Wainwright Global Investment Conference
    17 May 2022
    www.inflarx.de
  • Marinomed to attend several upcoming investor conferences
    17 May 2022
    www.marinomed.com
  • InflaRx Reports First Quarter 2022 Financial and Operating Results and Provides Strategic Update
    12 May 2022
    www.inflarx.de
  • HepaRegeniX reports positive topline results of its Phase 1 Clinical Trial of HRX-0215, a First-In-Class MKK4 inhibitor
    12 May 2022
    www.heparegenix.com/
  • World leading C. difficile scientists to present landmark data on the ability of NTCD-M3 to colonise the gut after antibiotic administration
    12 May 2022
    www.destinypharma.com
  • avateramedical robot-assisted surgery system progresses to clinical use
    10 May 2022
    www.avateramedical.com
  • Andera Partners supports Tubulis in a €60 million Series B financing to accelerate the development of its ADCs
    03 May 2022
    www.anderapartners.com